  See all
 |
Articles: Pharmacoeconomics |
Prior Articles
Costing Infectious Disease Outbreaks for Economic Evaluation: A Review for Hepatitis A
PharmacoEconomics, 07/14/09
Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data
Alimentary Pharmacology and Therapeutics, 07/14/09 Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients
Diabetes, Obesity and Metabolism, 07/14/09 Pharmacoeconomics of Sedation in the ICU
Critical Care Clinics, 07/13/09 The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations
PharmacoEconomics, 07/13/09 The Cost and Impact of Health Conditions on Presenteeism to Employers: A Review of the Literature
PharmacoEconomics, 07/10/09 The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics
PharmacoEconomics, 07/10/09 Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis
Current Medical Research and Opinion, 07/09/09 Alvimopan for postoperative ileus
American Journal of Health-System Pharmacy, 07/08/09 Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK
Vaccine, 07/08/09 Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK
Current Medical Research and Opinion, 07/06/09 Potential Clinical and Economic Outcomes of CYP2C9 and VKORC1 Genotype-Guided Dosing in Patients Starting Warfarin Therapy
Clinical Pharmacology & Therapeutics, 07/02/09 Rapid Infliximab Infusions in Pediatric Inflammatory Bowel Disease
Journal of Pediatric Gastroenterology and Nutrition, 07/01/09 Estimation of economic costs associated with transfusion dependence in adults with MDS
Current Medical Research and Opinion, 07/01/09 Long-term cost-effectiveness of clopidogrel in STEMI patients
International Journal of Cardiology, 06/30/09 Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK
Current Medical Research and Opinion, 06/30/09 Insomnia-related comorbidities and economic costs among a commercially insured population in the United States
Current Medical Research and Opinion, 06/29/09 Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective
Current Medical Research and Opinion, 06/26/09
Exclusive Author Commentary A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US
Current Medical Research and Opinion, 06/25/09 Absenteeism and health-benefit costs among employees with MS
Current Medical Research and Opinion, 06/25/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
153 Available Pages
|
|
